Cost-Effectiveness of Masked Hypertension Screening and Treatment in US Adults With Suspected Masked Hypertension: A Simulation Study

Abstract BACKGROUND Recent US blood pressure (BP) guidelines recommend using ambulatory BP monitoring (ABPM) or home BP monitoring (HBPM) to screen adults for masked hypertension. However, limited evidence exists of the expected long-term effects of screening for and treating masked hypertension. ME...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hypertension 2022-08, Vol.35 (8), p.752-762
Hauptverfasser:	Green, Matthew B, Shimbo, Daichi, Schwartz, Joseph E, Bress, Adam P, King, Jordan B, Muntner, Paul, Sheppard, James P, McManus, Richard J, Kohli-Lynch, Ciaran N, Zhang, Yiyi, Shea, Steven, Moran, Andrew E, Bellows, Brandon K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antihypertensive Agents - therapeutic use Blood Pressure - physiology Blood Pressure Monitoring, Ambulatory - methods Cost-Benefit Analysis Humans Hypertension - diagnosis Hypertension - drug therapy Hypertension - epidemiology Masked Hypertension - diagnosis Masked Hypertension - drug therapy Masked Hypertension - epidemiology Original Contributions
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract BACKGROUND Recent US blood pressure (BP) guidelines recommend using ambulatory BP monitoring (ABPM) or home BP monitoring (HBPM) to screen adults for masked hypertension. However, limited evidence exists of the expected long-term effects of screening for and treating masked hypertension. METHODS We estimated the lifetime health and economic outcomes of screening for and treating masked hypertension using the Cardiovascular Disease (CVD) Policy Model, a validated microsimulation model. We simulated a cohort of 100,000 US adults aged ≥20 years with suspected masked hypertension (i.e., office BP 120–129/
ISSN:	0895-7061 1941-7225 1941-7225
DOI:	10.1093/ajh/hpac071